Pharmaceutical dosage form

US9750701B2 · kind B2 · utility

Assignee

• GRÜNENTHAL GMBH · DE

Inventors

• Eugeen Marie Jozef Jans · Meerhout, BE
• Filip René Irena Kiekens · Geel, BE
• Jody Firmin Marceline Voorspoels · Reningelst, BE
• Anne Faure · Vosselaar, BE
• Iris Ziegler · Simmerath, DE
• Elisabeth ARKENAU-MARIC
• Lutz Barnscheid · Mönchengladbach, DE
• Johannes BARTHOLOMÄUS · Aachen, DE
• MARC FREVEL · Monschau, DE
• Eric Galia · Jülich, DE
• ANDREA SCHÜESSELE · Berlin, DE

Key dates

• Filing date: Dec 11, 2015
• Grant date: Sep 5, 2017
• Expiry date: Dec 11, 2035

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10T428/24479
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to a pharmaceutical dosage form, preferably with controlled release of a pharmacologically active compound (A) contained therein, the pharmaceutical dosage form very preferably being tamper-resistant and most preferably having a breaking strength B1 of at least 500 N in direction of extension E1 and having a breaking strength B2 of less than 500 N in direction of extension E2.